Technical note: Beamlet-free optimization for Monte-Carlo-based treatment planning in proton therapy.

Med Phys

Center of Molecular Imaging, Radiotherapy and Oncology, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Louvain-La-Neuve, Belgium.

Published: January 2024

Background: Dose calculation and optimization algorithms in proton therapy treatment planning often have high computational requirements regarding time and memory. This can hinder the implementation of efficient workflows in clinics and prevent the use of new, elaborate treatment techniques aiming to improve clinical outcomes like robust optimization, arc, and adaptive proton therapy.

Purpose: A new method, namely, the beamlet-free algorithm, is presented to address the aforementioned issue by combining Monte Carlo dose calculation and optimization into a single algorithm and omitting the calculation of the time-consuming and costly dose influence matrix.

Methods: The beamlet-free algorithm simulates the dose in proton batches of randomly chosen spots and evaluates their relative impact on the objective function at each iteration. Based on the approximated gradient, the spot weights are then updated and used to generate a new spot probability distribution. The beamlet-free method is compared against a conventional, beamlet-based treatment planning algorithm on a brain case and a prostate case.

Results: The beamlet-free algorithm maintained a comparable plan quality while largely reducing the dependence of computation time and memory usage on the number of spots.

Conclusion: The implementation of a beamlet-free treatment planning algorithm for proton therapy is feasible and capable of achieving treatment plans of comparable quality to conventional methods. Its efficient usage of computational resources and low spot dependence makes it a promising method for large plans, robust optimization, and arc proton therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.16813DOI Listing

Publication Analysis

Top Keywords

treatment planning
16
proton therapy
12
beamlet-free algorithm
12
dose calculation
8
calculation optimization
8
time memory
8
robust optimization
8
optimization arc
8
planning algorithm
8
beamlet-free
6

Similar Publications

Pancreatic surgery is considered one of the most challenging interventions by many surgeons, mainly due to retroperitoneal location and proximity to key and delicate vascular structures. These factors make pancreatic resection a demanding procedure, with successful rates far from optimal and frequent postoperative complications. Surgical planning is essential to improve patient outcomes, and in this regard, many technological advances made in the last few years have proven to be extremely useful in medical fields.

View Article and Find Full Text PDF

New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making.

BioDrugs

January 2025

Department of Neurology, Neuroscience Clinical Research Center (NCRC) and Integrated Myasthenia Gravis Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Charitéplatz 1, Germany.

Myasthenia gravis (MG) is a rare autoimmune disease characterised by exertion-induced muscle weakness that can lead to potentially life-threatening myasthenic crises. Detectable antibodies are directed against specific postsynaptic structures of the neuromuscular junction. MG is a chronic condition that can be improved through therapies, but to date, not cured.

View Article and Find Full Text PDF

On-pitch rehabilitation is a crucial part of returning to sport after injury in elite soccer. The () initially offered a framework for practitioners to plan on-pitch rehabilitation, focusing on physical preparation and sport specificity. However, our experiences with the , combined with recent research in injury neurophysiology, point to a need for an updated model that integrates practice design and physical-cognitive interactions.

View Article and Find Full Text PDF

"It's Like You're Feeding Your Child Twice": Barriers and Facilitators to Human Milk Feeding Children With Cystic Fibrosis.

Pediatr Pulmonol

January 2025

Department of Pediatrics, Division of Pulmonary, Allergy/Immunology, Cystic Fibrosis and Sleep, Emory University, Atlanta, Georgia, USA.

Background: Cystic Fibrosis Foundation guidelines recommend human milk (HM) as the ideal source of nutrition for children with CF (cwCF). Despite known pulmonary and nutritional benefits, fewer cwCF ever receive HM compared to the general population. Early nutrition choices are preference-sensitive, yet little is known about the factors that impede or sustain HM feeding among parents of cwCF.

View Article and Find Full Text PDF

Background: Photodynamic therapy (PDT) is a noninvasive cancer treatment that works by using light to stimulate the production of excessive cytotoxic reactive oxygen species (ROS), which effectively eliminates tumor cells. However, the therapeutic effects of PDT are often limited by tumor hypoxia, which prevents effective tumor cell elimination. The oxygen (O) consumption during PDT can further exacerbate hypoxia, leading to post-treatment adverse events.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!